Emotional Faces Memory Task News Today

The latest in mood disorder news, all in one place.

The Rejoyn therapy app was approved by the FDA as add-on treatment for adults with depression who are already taking an antidepressant.

Doctors could start prescribing this first-of-its-kind digital treatment later this year.

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.

(CNN) — The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.Rejoyn, made by<a class="excerpt-read-more" href="https://wsvn.com/news/us-world/fda-clears-first-digital-treatment-for-depression-but-experts-caution-that-research-is-still-early/">Read More</a>

Rejoyn is an app intended for use alongside antidepressant medications for people with major depressive disorder.

It is “designed to act like physical therapy for the brain,” a scientific advisor says.

It is “designed to act like physical therapy for the brain,” a scientific advisor says.

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.